Manchester City

Noted (AI summary) Greater Manchester Police acknowledges the absence of a specific policy on handcuffing during search warrant executions, but states that use of force is a case-by-case decision guided by legislation, the National Decision Model, and consideration of occupants' vulnerabilities.

Noted (AI summary) The Department of Health and Social Care acknowledges concerns regarding the use of Nearest Relative powers under the Mental Health Act. The response notes the Responsible Clinician's powers to bar requests for discharge and states the government does not intend to amend the Nearest Relative powers.

Noted (AI summary) The Secretary of State acknowledges concerns about including 'obesity' as an indicator of abuse and neglect in safeguarding guidance, highlighting existing guidance on safeguarding children's welfare and health. They note existing initiatives to improve access to services for children living with overweight or obesity and refer to the Independent Review of Children’s Social Care, stating that the concerns will be considered in the context of the review's recommendations.

Noted (AI summary) UCAS provides context on how students can share information about support needs within their application and how universities then arrange support. They highlight that the information is optional and handled confidentially, and doesn't impact academic judgement.

Noted (AI summary) NICE acknowledges the concerns but states it cannot influence changes to the EMIS system. They highlight existing guidelines on medicines adherence (CG76) and depression management (CG90) that contain relevant recommendations. The RCGP will open a dialogue with the Royal Pharmaceutical Society to consider in more detail the issue of patients not collecting prescriptions, and recommends that much greater integration of pharmacy and GP IT systems will likely be needed. EMIS confirmed that their software was working as designed and complies with NHS Digital requirements and are presently considering a number of potential digital tools to aid further patient compliance; they welcome a discussion with stakeholders to create best practice for managing this risk. The practice uses EMIS Web software and outlines the three methods by which patients can request repeat prescriptions, also noting that there is no system to alert them if a patient is not requesting their repeat medications on a month-by-month basis and expressing concerns about the resources needed to respond to such alerts.

Noted (AI summary) The RCPCH acknowledges the concern about Vitamin D supplementation advice in the Red Book, but states that the current edition already contains relevant guidance. They suggest the issue is one of professional practice rather than a deficiency in College standards. NICE states that their guideline PH56 already recommends including questions about vitamin D supplements in the Red Book, and that the RCPCH is best placed to amend the book's content. NICE will liaise with NHSX and NHS Digital to improve alignment between digital content and NICE guidance. They will consider the coroner's report when the guideline is next reviewed. The Department acknowledges concerns about vitamin D supplementation and highlights existing guidance and the Healthy Start scheme. They refer to an ongoing review into improving health outcomes in babies and young children but do not commit to any specific changes to vitamin D policy.

Noted (AI summary) The Greater Manchester Cardiac Network will review how they can support and extend work at MFT to improve the heart care pathway for quicker diagnosis and treatment of patients requiring TAVI. The Department of Health and Social Care acknowledges the concerns and notes that NICE is developing a clinical guideline on heart valve disease in adults, while the Manchester University NHS Foundation Trust and the Greater Manchester Cardiac Network are working on improving diagnosis and treatment processes. NICE references existing guidelines on chronic heart failure and notes the development of a clinical guideline on heart valve disease presenting in adults, which will consider referral indications, and the concerns raised have been highlighted to the guideline developers. BCIS will contact its members to review local referral pathways for TAVI procedures to expedite treatment and prevent delays, and supports moves to ensure adequate capacity for TAVI candidates.